| 26th Apr 2024 7:00 am |
RNS |
Cancellation - C4X Discovery Holdings plc |
| 25th Apr 2024 7:00 am |
RNS |
Last day of dealings and update on cancellation |
| 23rd Apr 2024 3:35 pm |
RNS |
Holding(s) in Company |
| 19th Apr 2024 6:00 pm |
RNS |
C4X Discovery Holdings |
| 15th Apr 2024 12:37 pm |
RNS |
Result of General Meeting |
| 9th Apr 2024 10:58 am |
RNS |
Director/PDMR Share Purchases |
| 27th Mar 2024 7:00 am |
RNS |
Proposed Voluntary Delisting |
| 27th Mar 2024 7:00 am |
RNS |
Interim results |
| 23rd Jan 2024 1:57 pm |
RNS |
Result of AGM |
| 18th Jan 2024 7:00 am |
RNS |
Board Update |
| 4th Jan 2024 2:45 pm |
RNS |
Holding(s) in Company |
| 3rd Jan 2024 7:00 am |
RNS |
AstraZeneca $11m milestone payment to C4XD |
| 18th Dec 2023 3:31 pm |
RNS |
Posting of 2023 Annual Report and Notice of AGM |
| 14th Dec 2023 7:00 am |
RNS |
Full Year Results |
| 7th Dec 2023 7:00 am |
RNS |
Notice of Results |
| 5th Oct 2023 2:35 pm |
RNS |
Holding(s) in Company |
| 2nd Oct 2023 12:36 pm |
RNS |
Block listing Interim Review |
| 29th Sep 2023 11:14 am |
RNS |
Grant of Options and Directors Dealing |
| 28th Sep 2023 3:52 pm |
RNS |
Holding(s) in Company |
| 1st Sep 2023 7:00 am |
RNS |
Total Voting Rights |
| 18th Aug 2023 12:45 pm |
RNS |
Exercise of Options, Issue of Equity and TVR |
| 1st Aug 2023 7:00 am |
RNS |
Divestment of Orexin-1 to Indivior for £15.95m |
| 20th Jun 2023 7:00 am |
RNS |
C4X Discovery Holdings plc: Board Change |
| 1st Jun 2023 7:00 am |
RNS |
MALT-1 Inhibitor Programme Update |
| 26th Apr 2023 7:00 am |
RNS |
Half Year Results |
| 19th Apr 2023 7:00 am |
RNS |
Notice of Results |
| 8th Mar 2023 2:49 pm |
RNS |
Block Listing Interim Review |
| 22nd Feb 2023 7:00 am |
RNS |
C4XD and Garvan Institute collaboration |
| 24th Jan 2023 11:47 am |
RNS |
Result of AGM |
| 19th Jan 2023 7:00 am |
RNS |
MALT-1 Inhibitor Programme Update |
| 10th Jan 2023 7:00 am |
RNS |
Nick Ray Appointed as Chief Scientific Officer |
| 19th Dec 2022 4:52 pm |
RNS |
Posting of 2022 Annual Report and Notice of AGM |
| 15th Dec 2022 7:00 am |
RNS |
Full Year Results |
| 28th Nov 2022 2:31 pm |
EQS |
C4X Discovery signs potential $402mln deal |
| 28th Nov 2022 9:00 am |
RNS |
Notice of Final Results |
| 28th Nov 2022 7:00 am |
RNS |
C4XD Agreement with AstraZeneca |
| 1st Nov 2022 2:03 pm |
RNS |
Exercise of Options, Issue of Equity and TVR |
| 20th Oct 2022 7:00 am |
RNS |
C4XD and HitGen to collaborate in inflammation |
| 4th Oct 2022 2:56 pm |
RNS |
Holding(s) in Company |
| 22nd Sep 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
